Syra Health Q2 EPS $(0.21) Misses $(0.19) Estimate, Sales $1.97M Beat $1.79M Estimate
Portfolio Pulse from Benzinga Newsdesk
Syra Health (NASDAQ:SYRA) reported Q2 earnings per share (EPS) of $(0.21), missing the analyst estimate of $(0.19). However, the company reported sales of $1.97 million, beating the estimate of $1.79 million. This represents a significant year-over-year sales increase of 101.17%.
August 08, 2024 | 11:36 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Syra Health reported a Q2 EPS of $(0.21), missing the $(0.19) estimate, but achieved sales of $1.97M, beating the $1.79M estimate. Sales increased by 101.17% YoY.
While Syra Health missed EPS estimates, the significant beat in sales and the substantial year-over-year growth in revenue could offset the negative sentiment from the EPS miss. This mixed result is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100